2018 Year in Review - Immune Therapy Gets a Boost From The Princess Margaret Research Team

07/01/2019


T-Cell_Article_Header-1.jpg

2018 Year in ReviewWe’re looking back at some of the most impactful research discoveries from Princess Margaret Cancer Centre in the past year.

A molecule, engineered by a research team led by Princess Margaret Cancer Centre Senior Scientist Dr. Naoto Hirano, may have the potential to enhance the effectiveness of existing immune therapies. The findings were published yesterday in the prestigious journal Nature Medicine. The type of immune therapy relevant to Dr. Hirano's work is known as chimeric antigen receptor (CAR) T-cell therapy – a therapy that helps patients' own immune cells, known as T-cells, to identify and fight cancer cells.

Read the full story here